Fitaro pre-filled syringe 1mg (Semaglutide) Incepta Pharmaceuticals Ltd

£132.00

Fitaro pre-filled syringe 1mg contains Semaglutide from Incepta Pharmaceuticals, formulated for in-vitro research examining GLP-1 receptor mechanisms and metabolic pathway studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Fitaro pre-filled syringe 1mg (Semaglutide) Incepta Pharmaceuticals Ltd
Fitaro pre-filled syringe 1mg (Semaglutide) Incepta Pharmaceuticals Ltd
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research-Grade Semaglutide Solution Overview

Fitaro pre-filled syringe 1mg is a pharmaceutical-grade GLP-1 receptor agonist preparation containing Semaglutide, manufactured by Incepta Pharmaceuticals Ltd for advanced laboratory investigation. This synthetic peptide analogue demonstrates specific binding affinity for glucagon-like peptide-1 receptors, making it valuable for researchers studying incretin system mechanisms and cellular signaling pathways. The pre-filled syringe format ensures standardised dosing precision for experimental protocols requiring consistent compound delivery. Laboratories investigating metabolic regulation, glucose homeostasis mechanisms, and GLP-1 receptor pharmacology utilise Semaglutide preparations to examine receptor binding dynamics and downstream signaling cascades. Researchers at Stroid UK Shop source this preparation for studies requiring pharmaceutical-grade peptide standards.

Laboratory Research Applications

Research teams investigate Semaglutide’s interactions with GLP-1 receptors to understand incretin system modulation and its effects on cellular metabolism. Studies examine the compound’s mechanism involving cyclic adenosine monophosphate (cAMP) pathway activation and subsequent intracellular signaling events. Laboratories studying pancreatic beta-cell function analyse Semaglutide’s effects on insulin secretion pathways in isolated cell preparations. Metabolic research protocols investigate the compound’s influence on gastric emptying mechanisms and appetite regulation centers through controlled experimental models. Researchers examining cardiovascular protection mechanisms study Semaglutide’s effects on endothelial function and vascular biology. Those researching best fat burner compounds investigate its metabolic pathway influences. Advanced protocols examine neuroprotective properties and potential brain-derived neurotrophic factor modulation. Studies complement research using SARMs and peptides for comprehensive metabolic investigations.

Technical Specifications

Fitaro Pre-filled Syringe Specifications
Parameter Value
Active Compound Semaglutide
Concentration 1mg per syringe
Manufacturer Incepta Pharmaceuticals Ltd
Product Form Pre-filled syringe
CAS Number 910463-68-2
Molecular Formula C187H291N45O59
Molecular Weight 4113.58 g/mol
Storage Temperature 2-8°C refrigerated
Stability Verify with product documentation
Purity As per manufacturer specifications

Research Compliance Statement

Fitaro pre-filled syringe 1mg containing Semaglutide is supplied exclusively for in-vitro laboratory research and analytical purposes. This pharmaceutical preparation is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate storage conditions and follow institutional protocols for peptide handling. All experimental work should comply with relevant laboratory safety guidelines and regulatory requirements for research chemical use. Purchase and use of this compound confirms acceptance of research-only applications under appropriate scientific supervision.

Related